Abstract: Disclosed are surfactant compositions comprising: (a) at least one alkoxylated glycol ether; and (b) at least one compound in accordance with Formula VII; where x is from about 1 to about 100, and each R4 is independently H or an alkyl moiety having from about 1 to about 2 carbon atoms, provided that the total number of carbon atoms within each x unit is not greater than about 8.

Abstract: The invention relates to the use in food products, such as spreads, sauces, ice-cream, soups, bakery products, and confectionery products, and cosmetic products, such as creams, lotions, lipsticks, soap bars, and skin or hair oils, of an oil having an oleic acid content of more than 40 wt % and a stearic acid content of more than 12 wt % based on the total fatty acid content of said oil, and wherein a maximum of 10 wt % of the fatty acid groups in the stereospecifically numbered-2 position of the triacylglycerol molecules constituting the oil are saturated fatty acid groups.

Abstract: An out-space actuator is selected to access an out-space user interface for a document editor program. An out-space actuator is associated with an in-space user interface having a displayed document. When the out-space actuator is selected, an out-space user interface is displayed that includes an expanded feature selection surface. The out-space user interface may be used to display one or more status panes for providing status information about a document being edited in the in-space user interface. Application features for affecting changes to a given document's status may be exposed in the out-space interface in proximity to associated status information. An out-space communication user interface (UI) component may be temporarily displayed in the document in-space user interface to communicate document status information that is presently available in the out-space user interface. A message bar may be displayed in the in-space user interface for communicating information from the out-space user interface.

Abstract: The invention relates to a novel fructofuranosidase activity for obtaining the prebiotic oligosaccharide 6-kestose. One object of the invention is to characterize a novel transfructosylase activity which is associated with the extracellular invertase of Schwanniomyces occidentalis (specifically the strains selected from the group consisting of ATCC260077, ATCC7410 and ATCC20499) and which can be used to obtain prebiotic oligosaccharides, mainly 6-kestose, which are widely used in the food industry. Another object of the invention relates to the method for obtaining an enzymatic product as well as to the substantially pure enzyme with fructofuranosidase activity.

Abstract: The invention relates to a method of obtaining industrially-viable prebiotic oligosaccharides, using a novel extracellular enzyme (fructofuranosidase) of Xanthophyllomyces dendrorhous, which is characterised in that it also has transfructosilase activity. The invention also relates to a method of obtaining an enzymatic product with fructofuranosidase activity, as well as the substantially-pure enzyme with said activity. The enzymatic product and the enzyme offer the advantage of having a high performance spectrum, high heat stability and a high specific activity. Said prebiotic oligosaccharaides are used in food.

Abstract: The invention relates to a novel microalga species and to the use thereof for animal and/or human consumption and in the production of carotenoids. A novel strain of Scenedesmus has been isolated at the Las Palmerillas experimental station, Cajamar, identified as microorganisms that had not been previously registered by the University of Gottinghem and deposited within the Culture Collection of Alagae and Protozoa (CCAP) as Scenedesmus almeriensis. The novel strain, which can be used for animal and/or human consumption, produces large quantities of carotenoids, particularly lutein and beta-carotene. Scenedesmus almeriensis grows adequately in a wide range of temperatures from 10° C. to 40° C. at a pH of between 7 and 9.5 and can tolerate high concentrations of copper, up to 1 mg/L. The microalgal strain is grown in a 4000 L photobioreactor, into which the culture is inserted mechanically, and produces less than 4 mg of lutein per gram of dry material.

Abstract: Carnitine and other muscle protectors are useful to prevent side effects of aplidine and aplidine analogues.

Abstract: The invention relates to plant seeds that contain an oil having an oleic acid content of more than 40 wt % and a stearic acid content of more than 12 wt % based on the total fatty acid content of said oil, and wherein a maximum of 10 wt % of the fatty acid groups in the sn-2 position of the TAG molecules constituting the oil are saturated fatty acid groups. The invention also relates to plants that can be grown from the seeds, oil that can be extracted from the seeds, and to methods for obtaining the seeds, plants and oil.

Abstract: A surfactant concentrate including a compound according to general formula (III): R1—O—[CH2—CH2O]n—H, and a compound according to general formula (IV): is provided. A liquid, surfactant composition including the surfactant concentrate in water is also provided. A surfactant concentrate and a liquid, surfactant composition including a compound according to general formula (V): R1—O—[CH2—CH2O]n—A and a compound according to general formula (VI): are also provided. Methods for stabilizing an emulsion polymer or polymer dispersion, and for adding to an emulsion polymer reaction or a polymer dispersion to carry out the polymerization reaction, are also provided.

Abstract: An anionic surfactant concentrate and method for making includes providing compound (I) R1—OH where R1 represents a branched C6-22 radical with average branching of about 2-8 per radical; providing compound (II): where R2 represents a C8-16 radical; mixing (I) and (II); ethoxylating to obtain a reaction product; reacting with a sulfating, phosphating, or sulfitation agent to obtain R1—O—[CH2—CH2O]n—A and where R1 represents a branched C6-22 radical with average branching of about 2-8, R2 represents a C8-16 radical, A represents —SO3M, —PO3M, —PO3M2, —OCCH2CH(SO3Na) COO—, or HOOCCH2CH(SO3Na)COO—, M represents a positive counterion, n represents a value from 0-100, and x and y each represents a value from 0-100, where the sum of x and y represents a value of at least 1 to 100 are provided. Anionic surfactant compositions containing the concentrate and methods for stabilizing are also provided.

Abstract: A computer implemented method, apparatus, and computer usable program code for managing messages for an instant messaging conversation. A determination is made as to whether the selected party should receive the messages already exchanged in the instant messaging conversation in response to a user input during the instant messaging conversation with respect to a selected party. The messages are sent to the selected party in response to a determination that the selected party should receive the plurality of messages.

Abstract: The present invention relates to a method of dyeing a substrate with a reactive dyestuff in supercritical or near supercritical carbon dioxide, said substrate being selected from the group consisting of cellulose fibres; modified cellulose fibres; protein fibres; synthetic fibres and any combination thereof, wherein the method comprises dyeing said substrate by contacting the substrate with supercritical or near supercritical carbon dioxide containing a reactive dyestuff and one or more acids in a concentration of at least 0.05 mol.

Abstract: A carbamate of formula (I), wherein R1 represents wherein R2 represents a benzyl, phenethyl, furan-2-ylmethyl, furan-3-ylmethyl, thiophen-2-ylmethyl or thiophen-3-ylmethyl group or a straight or branched alkyl group having 3 or 8 carbon atoms, an alkenyl group having 3 to 8 carbon atoms, or a cycloalkyl group of 3 to 6 carbon atoms; p is 1 or 2 and the substitution in the azoniabicylic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons; or a pharmaceutically acceptable salt thereof. The pharmaceutically acceptable salt may be of formula (II).

Abstract: The present invention relates to a method of dyeing a substrate with a reactive dyestuff in supercritical or near supercritical carbon dioxide, said substrate being selected from the group consisting of cellulose fibres, modified cellulose fibres, protein fibres and of synthetic fibres, or any combination thereof, wherein the method comprises the subsequent steps of: pre-treating the substrate by wetting the substrate with a fluid medium containing at least 10 wt. %, preferably at least 40 wt. % of one or more organic hydrogen bond acceptor compounds selected from the group consisting of C1-C6 alkanols, dimethyl sulfoxide, dimethylformamide, acetone, butan-2-one, dimethyl ether, methyl acetate and ethyl acetate; dyeing the substrate by contacting the pre-treated substrate with supercritical or near supercritical carbon dioxide containing a reactive dyestuff.

Abstract: This invention relates to a method of producing and dispensing a foam using a “high lower alcohol content”(>40% v/v of a C1-4 alcohol) liquid composition. The liquid compositions comprise an alcohol, C1-4(>40% v/v), a silicone-based surfactant of at least 0.001% by weight to prepare a foamable composition, 0-10% w/w of additional minor components added to obtain the desired performance (a foamable composition), and the balance being purified water. The compositions may include emulsifier-emollients and mosturizers, secondary surfactants, foam stabilizers, fragrances, antimicrobial agents, other type of medicinal ingredients, and the like ingredients or additives or combinations thereof commonly added to alcohol gels or foams, aerosol compositions or to toiletries, cosmetics, pharmaceuticals and the like.

Abstract: Compounds of formula I wherein n, m, p, q, y, R1 R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating artherosclerosis and its sequelae.

Abstract: Compounds of formula I wherein n, m, p, q, Y, R1 R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.

Abstract: The present invention discloses compounds of formula I wherein A, n, m, j, q, y, W, X, Y, Z, R1, R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and its sequelae.

Abstract: This invention relates to a “high lower alcohol content” (>40% v/v of a C1-4 alcohol) liquid composition able to be dispensed as a stable foam with the use of non-propellant foam dispensing devices from non-pressurized containers The liquid compositions comprise an alcohol, C1-4 (>40% v/v), a silicone-based surfactant of at least 0.001% by weight to prepare a foamable composition, 0-10% w/w of additional minor components added to obtain the desired performance (a foamable composition), and the balance being purified water. The compositions may include emulsifier-emollients and mosturizers, secondary surfactants, foam stabilizers, fragrances, antimicrobial agents, other type of medicinal ingredients, and the like ingredients or additives or combinations thereof commonly added to alcohol gels or foams, aerosol compositions or to toiletries, cosmetics, pharmaceuticals and the like.

Abstract: The present invention discloses compounds of formula (I) wherein A, n, q, K, W, X, Y; Z, R1, R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and its sequelae.